BSE filing, NSE: HEALTHX. Summary written from the filing by ALFA Finder's alert engine.
Health X Platform Ltd: key numbers
- Share price
- ₹273.70
- Market cap
- ₹870.6 Cr
- Revenue (annual)
- ₹1,319 Cr
- Net profit (annual)
- ₹1.18 Cr
- P/E (TTM)
- -43.1×Sector 53.4×
- Promoter holding
- 74.07%+0.00% QoQ
- FII holding
- 2.32%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Health X Platform Ltd
All →Health X Platform Other Announcement
Health X Platform Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI Listing Regulations.
Health X Platform Annual General Meeting
Health X Platform Limited held its 37th Annual General Meeting on September 28, 2026. Members transacted ordinary and special business, including financial statements and director re-appointments.
Health X Platform Other Announcement
Health X Platform Limited dispatched letters to shareholders with unregistered emails, providing web-links for the FY2025-26 Annual Report and 37th AGM notice.
Health X Platform Annual Report
Health X Platform Limited has filed its Annual Report for the financial year 2025-26. The company reported a consolidated total revenue of Rs. 1,319.27 Crore for the period.
Health X Platform Annual General Meeting
Health X Platform Limited will hold its 37th Annual General Meeting on September 28, 2026, via video conferencing. The meeting notice and annual report will be submitted later.
Health X Platform Earnings Call Transcript: Key Takeaways
Health X is aggressively scaling its digital B2B and B2C pharmacy platforms, showing strong top-line momentum while burning cash on technology and geographical expansion.
- Call
- Guides 100% growth
Other board meeting date announcements
All →Vedavaag Systems Board Meeting Date
Vedavaag Systems intimated a board meeting on 13 Nov 2026 to consider unaudited standalone and consolidated half-yearly financial results for September 2026. Trading window closes from 01 Oct to 16 Oct 2026.
Miven Machine Tools Board Meeting Date
Miven Machine Tools intimated a board meeting on 12 Nov 2026 to consider unaudited standalone quarterly results for September 2026. Trading window closes from 01 Oct to 16 Nov 2026.
Affordable Robotic & Automation Board Meeting Date
Affordable Robotic & Automation intimated a board meeting on 14 Nov 2026 to consider unaudited standalone and consolidated quarterly results for September 2026. Trading window closes from 01 Oct to 16 Nov 2026.
Norris Medicines Board Meeting Date
Norris Medicines Limited intimated a prior board meeting on 14 Nov 2026 to consider unaudited standalone quarterly results for September 2026. Trading window closed from 01 Oct to 16 Nov 2026.
Sahara Housingfina Corporation Board Meeting Date
Sahara Housingfina meets on 13 Nov 2026 to consider quarterly standalone unaudited results for September 2026. Trading window is not closed for this meeting.
Deccan Health Care Board Meeting Date
Deccan Health Care meets 13 Nov 2026 to consider half-yearly standalone and consolidated unaudited results for September 2026. Trading window stays closed from 01 Oct until 48 hours after results are declared.